APTALIS PHARMA INC Accounts Receivable
APTALIS PHARMA INC had Accounts Receivable of $88.01 million as of 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2012-02-10
- 2011-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $88.01M.
- 2011-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $75.62M.
- 2011-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $81.20M.
- 2010-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $32.38M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2011-12-31 | $88.01M 10-Q · filed 2012-02-10 |
| 2011-09-30 | $75.62M 10-Q · filed 2012-02-10 |
| 2011-06-30 | $81.20M 10-Q · filed 2011-08-12 |
| 2010-09-30 | $32.38M 10-K · filed 2011-12-20 |